Literature DB >> 29259443

A case of gradually manifesting McCune-Albright syndrome with a 10-year follow-up.

Tomoko Honda1, Fumiko Itoh1, Kimitoshi Nakamura2, Takashi Ohba1, Hidetaka Katabuchi1.   

Abstract

McCune-Albright syndrome (MAS) is characterized by fibrous dysplasia (FD) of bone, café-au-lait skin pigmentation, and precocious puberty. Here we report a case of a 12-year-old girl with MAS presenting sexual precocity as initial signs, followed by FD of bone with her growth. She was referred to our hospital because of breast budding and abnormal genital bleeding at the age of 2.8 years. On physical examination, her height and weight were greater than two standard deviations of the mean ranges. Hormonal analysis revealed an elevated serum estradiol and suppressed luteinizing hormone and follicle-stimulating hormone production. Her bone age had advanced, and a 16-mm monocystic lesion was observed on her right ovary by pelvic ultrasonography. Considering the clinical and paraclinical findings, precocious pseudopuberty was suspected and periodic observations were started. Her estrogen "flare up" was transient and she had repeated similar episodes three times in the following 7 years. She complained of pain in her right hip at the age of 9.6 years, which was diagnosed as FD of bone by fluorodeoxyglucose-positron emission tomography. Although no café-au-lait skin pigmentation was observed, we made a preliminary diagnosis of MAS. Because clinical evidence for MAS can appear later in the course of recurrent autonomous cysts, careful observation and periodical assessments of patients with suspected MAS is necessary.

Entities:  

Keywords:  Fibrous dysplasia of bone; McCune–Albright syndrome; Positron‐emission tomography; Precocious pseudopuberty; Sexual precocity

Year:  2016        PMID: 29259443      PMCID: PMC5715861          DOI: 10.1007/s12522-016-0242-z

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  8 in total

Review 1.  Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy.

Authors:  M D Ringel; W F Schwindinger; M A Levine
Journal:  Medicine (Baltimore)       Date:  1996-07       Impact factor: 1.889

2.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

Authors:  W F Schwindinger; C A Francomano; M A Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  McCune Albright Syndrome (MCAS): a case series.

Authors:  Sudha Rao; M P Colaco; M P Desai
Journal:  Indian Pediatr       Date:  2003-01       Impact factor: 1.411

4.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Authors:  L S Weinstein; A Shenker; P V Gejman; M J Merino; E Friedman; A M Spiegel
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

5.  Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.

Authors:  Serge Lumbroso; Françoise Paris; Charles Sultan
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

6.  The McCune-Albright syndrome: a lethal gene surviving by mosaicism.

Authors:  R Happle
Journal:  Clin Genet       Date:  1986-04       Impact factor: 4.438

Review 7.  McCune-Albright syndrome and disorders due to activating mutations of GNAS1.

Authors:  Alejandro Diaz; Marco Danon; John Crawford
Journal:  J Pediatr Endocrinol Metab       Date:  2007-08       Impact factor: 1.634

Review 8.  McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia.

Authors:  Michael T Collins; Frederick R Singer; Erica Eugster
Journal:  Orphanet J Rare Dis       Date:  2012-05-24       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.